After participating in this webinar, the learner will be able to:
- Recognize current methodologies and clinical indications for intragraft gene expression testing.
- Describe new opportunities afforded by emerging FFPE-based intragraft gene expression technologies.
- Understand the available data on the use of donor-derived cell-free DNA for solid organ transplants (kidney, pancreas, liver, heart, lung).
- Understand the limitations and future directions of available data on the use of donor-derived cell-free DNA for solid organ transplants.
- Explain the use of urine as a surrogate for kidney allograft biopsy.
- Discuss strategies to develop and validate robust biomolecular markers of kidney allograft status.
- Describe urinary cell biomolecular markers of human kidney allograft status.